Abstract:Objective To observe the efficacy,side effect and health economics values of the therapy of antidepressants combining atypical antipsychotics with different administration lengths,on nonpsychotic symptom,treatment-resistant depression. Methods 99 patients out of the randomized 4 groups of patients completed one year follow-up study.The 4 groups are the group of single therapy of fluoxetine(27 patients),the group of therapy of fluoxetine combining 1~2 months administration of olanzapine(28 patients),the group of therapy of fluoxetine combining 4~6 months administration of olanzapine(29 patients) and the group of therapy of fluoxetine combining 12 months administration of olanzapine(15 patients).At the starting point,measure of all patients in the four groups the HAMD,SDSS,weight and annual income ete at the end of 1 year follow-up study,measure of those patients the HAMD,weight.TESS and income of the past year,working hours,recurrent frequency and therapeutic sosts etc.The decreased scores of HAMD tests and the cure rates are used to evaluate the efficacy,the TESS scores and weight records are used to evaluate the side effect,and the working hours,annual income and therapeutic costs are used to evaluate the health economics values. Results All patients of the four groups improved at different degree comparing to their pre-therapeutic period.The group of therapy of fluoxetine combining 4~6 months administration of olanzapine and the group of therapy of fluoxetine combining 12 months administration of olanzapine were improved more significantly than the other two groups.No patients in the four groups showed severe side effects,but patients of the three groups of combination therapy had weight increase at different degree comparing with the fluoxetine single using group.In terms of annual income,working hours and recurrent frequency,the 4~6 months olanzapine combination group and the 12 months olanzapine combination group are superior to the other two groups.The 4~6 months olanzapine combination group is at lower therapeutic cost than the 12 months olanzapine combination group. Conclusions Therapy of olanzapine,the atypical antipsychotics,combining fluoxetine on nonpsychotic symptom,treatment-resistant depression has definite curative effect and less side effects.The most appropricate administration length of olanzapine in the combination is 4~6 months..

Efficacy and safety of olanzapine combined with fluoxetine in treatment of depression

A controlled trial of olanzapine and fluoxetine in treatment of negative symptoms of schizophrenia

A comparative study of treatment of depression:Mirtazapine vs.fluoxepine

A study on efficacy and safety of fluoxetine combined with olanzapine in the treatment of major depression

Olanzapine Versus Lithium in the Acute Treatment of Bipolar Mania: A Double-Blind, Randomized, Controlled Trial

Randomized Double-Blind Control Study of Olanzapine Augmented with Fluoxetine for Schizophrenia with Depression Symptom

A study of olanzapine and fluoxetine combination therapy on nonpsychotic symptom,treatment-resistant depression

The efficacy and safety of olanzapine combined with fluoxetine in the treatment of negative symptoms of schizophrenia:a systematic review

Efficacy of fluoxetine combined with psychological intervention for treatment of depressive patients with insomnia

A clinical study of combined Rhizoma Polygonati and fluoxetine in the treatment of depression

The Efficacy and Safety of Mirtazapine and Fluoxetine for Depression:A Meta-analysis

Control study of mirtazapine and fluoxetine in therapy of depression

[Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy]

A Study of the Efficacy and Safety of Olanzapine in the Treatment of Schizophrenia

Randomised, Double-Blind, Placebo-Controlled Study of Olanzapine in Patients with Bipolar I Depression

Optimized integration of fluoxetine and 7, 8-dihydroxyflavone as an efficient therapy for reversing depressive-like behavior in mice during the perimenopausal period.

The efficacy and safety of trazodone plus fluoxetine in the treatment of male depression patients

Effect observation of escitalopram combination with ziprasidone in the treatment of treatment-resistant depression

Efficacy and safety of low-dose amisulpride versus olanzapine-fluoxetine combination in post-schizophrenic depression: A randomized controlled trial

Efficacy and safety of quetiapine augmentation of antidepressants on depression

ComParison of different treatment regimens for refractory dePression efficacy